Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The rise, fall, and resurgence of immunotherapy in type 1 diabetes
Moufida Ben Nasr, Francesca D’Addio, Vera Usuelli, et al.
Pharmacological Research (2014) Vol. 98, pp. 31-38
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Experimental Diabetes Mellitus in Different Animal Models
Amin Al-Awar, Krisztina Kupai, Médea Veszelka, et al.
Journal of Diabetes Research (2016) Vol. 2016, pp. 1-12
Open Access | Times Cited: 259
Chemical composition, antioxidant, and anti-diabetic activities of ethyl acetate fraction of Stachys riederi var. japonica (Miq.) in streptozotocin-induced type 2 diabetic mice
Kandasamy Saravanakumar, SeonJu Park, Arokia Vijaya Anand Mariadoss, et al.
Food and Chemical Toxicology (2021) Vol. 155, pp. 112374-112374
Closed Access | Times Cited: 124
Current Concepts on the Pathogenesis of Type 1 Diabetes—Considerations for Attempts to Prevent and Reverse the Disease
Mark A. Atkinson, Matthias von Herrath, Alvin C. Powers, et al.
Diabetes Care (2015) Vol. 38, Iss. 6, pp. 979-988
Open Access | Times Cited: 132
PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes
Moufida Ben Nasr, Sara Tezza, Francesca D’Addio, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 416
Open Access | Times Cited: 123
Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism
Stefania Garbossa, Franco Folli
Reviews in Endocrine and Metabolic Disorders (2017) Vol. 18, Iss. 2, pp. 243-258
Closed Access | Times Cited: 120
Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway
Lei Du, Chengcheng Li, Xuan Qian, et al.
Pharmacological Research (2019) Vol. 146, pp. 104320-104320
Closed Access | Times Cited: 112
Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: A review of scientific findings and call for further research
Raphael N. Alolga, Gloria F. Nuer-Allornuvor, Eugene Dogkotenge Kuugbee, et al.
Pharmacological Research (2020) Vol. 152, pp. 104630-104630
Closed Access | Times Cited: 66
Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulation
Carl Engman, Yi Wen, Wilson S. Meng, et al.
Clinical Immunology (2015) Vol. 160, Iss. 1, pp. 103-123
Closed Access | Times Cited: 61
Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice
Sudhanshu P. Raikwar, Eun Mi Kim, William I. Sivitz, et al.
PLoS ONE (2015) Vol. 10, Iss. 1, pp. e0116582-e0116582
Open Access | Times Cited: 56
Type 1 diabetes and gut microbiota: Friend or foe?
Changyun Hu, F. Susan Wong, Wen Li
Pharmacological Research (2015) Vol. 98, pp. 9-15
Open Access | Times Cited: 54
The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: A systematic review of pre-clinical studies
Phiwayinkosi V. Dludla, Sithandiwe E. Mazibuko-Mbeje, Tawanda M. Nyambuya, et al.
Pharmacological Research (2019) Vol. 146, pp. 104332-104332
Closed Access | Times Cited: 47
The Gut Microbiota Modulates Glycaemic Control and Serum Metabolite Profiles in Non-Obese Diabetic Mice
Thomas U. Greiner, Tuulia Hyötyläinen, Mikael Knip, et al.
PLoS ONE (2014) Vol. 9, Iss. 11, pp. e110359-e110359
Open Access | Times Cited: 43
The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
Lucien Marchand, Emmanuel Disse, Stéphane Dalle, et al.
Acta Diabetologica (2019) Vol. 56, Iss. 12, pp. 1239-1245
Closed Access | Times Cited: 41
Cell therapy for type 1 diabetes
Cristian Loretelli, Emma Assi, Andy Joe Seelam, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 8, pp. 887-897
Open Access | Times Cited: 39
Advances in immunotherapy of type I diabetes
Qianqian Ni, Ngoc B. Pham, Wilson S. Meng, et al.
Advanced Drug Delivery Reviews (2018) Vol. 139, pp. 83-91
Closed Access | Times Cited: 38
Semisynthetic bile acids: a new therapeutic option for metabolic syndrome
Slavica Lazarević, Maja Đanić, Svetlana Goločorbin-Kon, et al.
Pharmacological Research (2019) Vol. 146, pp. 104333-104333
Closed Access | Times Cited: 36
The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma
Dilinaer Wusiman, Lei Guo, Zehao Huang, et al.
Pathology - Research and Practice (2022) Vol. 236, pp. 153934-153934
Open Access | Times Cited: 20
Immunotherapy as a treatment for type 1 diabetes mellitus in children and young adults: A comprehensive systematic review and meta-analysis
G. Salame, Vincent Hakim, Chebly Dagher, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0321727-e0321727
Open Access
Effect of 6-months’ vitamin D supplementation on residual beta cell function in children with type 1 diabetes: a case control interventional study
Atindra Mishra, Devi Dayal, Naresh Sachdeva, et al.
Journal of Pediatric Endocrinology and Metabolism (2015) Vol. 29, Iss. 4, pp. 395-400
Open Access | Times Cited: 38
Immunotherapy for type 1 diabetes
Davide Frumento, Moufida Ben Nasr, Basset El Essawy, et al.
Journal of Endocrinological Investigation (2017) Vol. 40, Iss. 8, pp. 803-814
Closed Access | Times Cited: 36
The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes
Parth Narendran, Thomas P. J. Solomon, Amy Kennedy, et al.
Diabetologia (2014) Vol. 58, Iss. 1, pp. 10-18
Open Access | Times Cited: 35
Preclinical and clinical results regarding the effects of a plant-based antidiabetic formulation versus well established antidiabetic molecules
Anca Ungurianu, Oana Cristina Șeremet, Elvira Gagniuc, et al.
Pharmacological Research (2019) Vol. 150, pp. 104522-104522
Closed Access | Times Cited: 35
Embryonic stem cell extracts improve wound healing in diabetic mice
Cristian Loretelli, Moufida Ben Nasr, Giorgio Giatsidis, et al.
Acta Diabetologica (2020) Vol. 57, Iss. 7, pp. 883-890
Closed Access | Times Cited: 30
Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes
Sigurd Lenzen
Diabetes/Metabolism Research and Reviews (2017) Vol. 33, Iss. 7
Closed Access | Times Cited: 31
Explaining the increased mortality in type 1 diabetes
Chiara Mameli
World Journal of Diabetes (2015) Vol. 6, Iss. 7, pp. 889-889
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top